Morningstar Investment Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,753
| Closed | -$1.68M | – | 168 |
|
|
2024
Q3 | $1.68M | Buy |
23,753
+951
| +4% | +$67.1K | 0.02% | 182 |
|
|
2024
Q2 | $1.9M | Buy |
22,802
+312
| +1% | +$26.1K | 0.02% | 166 |
|
|
2024
Q1 | $1.99M | Sell |
22,490
-22,112
| -50% | -$1.96M | 0.02% | 159 |
|
|
2023
Q4 | $4.33M | Buy |
44,602
+23,288
| +109% | +$2.26M | 0.02% | 161 |
|
|
2023
Q3 | $1.9M | Buy |
21,314
+661
| +3% | +$59K | 0.02% | 159 |
|
|
2023
Q2 | $1.85M | Buy |
20,653
+1,420
| +7% | +$127K | 0.02% | 156 |
|
|
2023
Q1 | $1.82M | Buy |
19,233
+1,163
| +6% | +$110K | 0.02% | 153 |
|
|
2022
Q4 | $1.88M | Buy |
18,070
+328
| +2% | +$34.2K | 0.03% | 145 |
|
|
2022
Q3 | $1.52M | Sell |
17,742
-1,132
| -6% | -$97K | 0.02% | 146 |
|
|
2022
Q2 | $1.58M | Buy |
18,874
+3,808
| +25% | +$319K | 0.02% | 153 |
|
|
2022
Q1 | $1.18M | Buy |
15,066
+2,613
| +21% | +$205K | 0.01% | 172 |
|
|
2021
Q4 | $1.1M | Buy |
12,453
+2,145
| +21% | +$190K | 0.01% | 174 |
|
|
2021
Q3 | $792K | Buy |
10,308
+996
| +11% | +$76.5K | 0.01% | 176 |
|
|
2021
Q2 | $777K | Buy |
9,312
+1,640
| +21% | +$137K | 0.01% | 176 |
|
|
2021
Q1 | $575K | Buy |
7,672
+4,056
| +112% | +$304K | 0.01% | 174 |
|
|
2020
Q4 | $317K | Sell |
3,616
-32
| -0.9% | -$2.81K | ﹤0.01% | 181 |
|
|
2020
Q3 | $278K | Buy |
3,648
+127
| +4% | +$9.68K | ﹤0.01% | 180 |
|
|
2020
Q2 | $430K | Sell |
3,521
-58
| -2% | -$7.08K | 0.01% | 164 |
|
|
2020
Q1 | $295K | Buy |
3,579
+98
| +3% | +$8.08K | 0.01% | 177 |
|
|
2019
Q4 | $294K | Sell |
3,481
-269
| -7% | -$22.7K | ﹤0.01% | 170 |
|
|
2019
Q3 | $253K | Sell |
3,750
-187
| -5% | -$12.6K | ﹤0.01% | 171 |
|
|
2019
Q2 | $337K | Sell |
3,937
-423
| -10% | -$36.2K | 0.01% | 184 |
|
|
2019
Q1 | $387K | Sell |
4,360
-636
| -13% | -$56.5K | 0.01% | 168 |
|
|
2018
Q4 | $425K | Sell |
4,996
-62
| -1% | -$5.27K | 0.01% | 158 |
|
|
2018
Q3 | $490K | Buy |
5,058
+532
| +12% | +$51.5K | 0.01% | 157 |
|
|
2018
Q2 | $426K | Buy |
4,526
+183
| +4% | +$17.2K | 0.01% | 161 |
|
|
2018
Q1 | $352K | Buy |
4,343
+247
| +6% | +$20K | 0.01% | 171 |
|
|
2017
Q4 | $365K | Sell |
4,096
-131
| -3% | -$11.7K | 0.01% | 172 |
|
|
2017
Q3 | $393K | Sell |
4,227
-78
| -2% | -$7.25K | 0.01% | 160 |
|
|
2017
Q2 | $391K | Sell |
4,305
-42
| -1% | -$3.82K | 0.01% | 158 |
|
|
2017
Q1 | $382K | Buy |
4,347
+1,375
| +46% | +$121K | 0.01% | 158 |
|
|
2016
Q4 | $246K | Buy |
2,972
+79
| +3% | +$6.54K | 0.01% | 174 |
|
|
2016
Q3 | $268K | Buy |
+2,893
| New | +$268K | 0.01% | 197 |
|